Guía de Práctica Clínica sobre Lupus Eritematoso Sistémico

793 Jarrett M, Schiffman G, Barland P, Grayzel A. Impaired response to pneumococcal
vaccine in systemic lupus erythematosus. Arthritis Rheum 1980; 23: 1287–1293.
794 McDonald E, Jarrett M, Schiffman G, Grayzel A. Persistence of pneumococcal antibodies
after immunization in patients with systemic lupus erythematosus. J Rheumatol 1984; 11:
306–308.
795 Elkayam O, Paran D, Caspi D, Litinsky I, Yaron M, Charboneau D et al. Immunogenicity
and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic
lupus erythematosus. Clin Infect Dis 2002; 34: 147–153.
796 Tarján P, Sipka S, Maro L, Nemes E, Lakos G, Gyimesi E et al. No short-term
immunological effects of Pneumococcus vaccination in patients with systemic lupus
erythematosus. Scand J Rheumatol 2002; 31: 211–215.
797 Battafarano DF, Battafarano NJ, Larsen L, Dyer PD, Older SA, Muehlbauek S et al.
Antigen-specific antibody responses in lupus patients following immunization. Arthritis
Rheum 1998; 41: 1828–1834.
798 Elkayam O, Paran D, Burke M, Zakut V, Ben-Yitshak R, Litinsky I et al. Pneumococcal
vaccination of patients with systemic lupus erythematosus: effects on generation of
autoantibodies. Autoimmunity 2005; 38: 493–496.
799 Bernatsky S, Clarke A, Ramsey-Goldman R. Malignancy and systemic lupus
erythematosus. Curr Rheumatol Rep 2002; 4: 351–358.
800 Gadalla SM, Amr S, Langenberg P, Baumgarten M, Davidson WF, Schairer C et al. Breast
cancer risk in elderly women with systemic autoimmune rheumatic diseases: a populationbased
case-control study. Br J Cancer 2009; 100: 817–821.
801 Bernatsky S, Ramsey-Goldman R, Labrecque J, Joseph L, Boivin J-F, Petri M et al.
Cancer risk in systemic lupus: an updated international multi-centre cohort study. J
Autoimmun 2013; 42: 130–135.
802 Liang J-A, Sun L-M, Yeh J-J, Lin W-Y, Chang S-N, Sung H-C et al. Malignancies
associated with systemic lupus erythematosus in Taiwan: a nationwide population-based
cohort study. Rheumatol Int 2012; 32: 773–778.
803 Kang KY, Kim HO, Yoon HS, Lee J, Lee WC, Ko H-J et al. Incidence of cancer among
female patients with systemic lupus erythematosus in Korea. Clin Rheumatol 2010; 29:
381–388.
804 Klumb EM, Pinto AC, Jesus GR, Jr MA, Jascone L, Gayer CR et al. Are women with
lupus at higher risk of HPV infection ? Lupus 2010; 19: 1485–1491.
805 Ognenovski V, Marder W, Somers E, Johnston C, JG F, Selvaggi S et al. Increased
incidence of cervical intraepithelial neoplasia in women with systemic lupus erythematosus
treated with intravenous cyclophosphamide. J Rheumatol 2004; 31: 1763–1767.
806 Anderson LA, Gadalla S, Morton LM, Landgren O, Warren JL, Berndt SI et al.
Population-based study of autoinmmune conditions and the risk of specific lymphoid
malignancies. Int J Cancer 2010; 125: 398–405.
GUÍA DE PRÁCTICA CLÍNICA SOBRE LUPUS ERITEMATOSO SISTÉMICO 495